1 March 2012
Scientists have come up with an experimental drug that holds promise for protecting the brain against the detrimental effects of a stroke.
The drug developed by the scientists at the Toronto Western Research Institute (TWRI), Krembil Neuroscience Center, is the first to achieve a neuroprotective effect in the complex brain of primates, in settings that simulate those of human strokes. ischemic stroke.
The new study shows how the drug, called a “PSD95 inhibitor” prevents brain cell death and preserves brain function when administered after a stroke has occurred.
“We are closer to having a treatment for stroke than we have ever been before,” said Dr. Michael Tymianski, TWRI Senior Scientist and the study’s lead author.